ENTRY       hsa04911                    Pathway
NAME        Insulin secretion - Homo sapiens (human)
DESCRIPTION Pancreatic beta cells are specialised endocrine cells that continuously sense the levels of blood sugar and other fuels and, in response, secrete insulin to maintain normal fuel homeostasis. Glucose-induced insulin secretion and its potentiation constitute the principal mechanism of insulin release. Glucose is transported by the glucose transporter (GLUT) into the pancreatic beta-cell. Metabolism of glucose generates ATP, which inhibits ATP-sensitive K+ channels and causes voltage-dependent Ca2+ influx. Elevation of [Ca2+]i triggers exocytotic release of insulin granules. Insulin secretion is further regulated by several hormones and neurotransmitters. Peptide hormones, such as glucagon-like peptide 1 (GLP-1), increase cAMP levels and thereby potentiate insulin secretion via the combined action of PKA and Epac2. Achetylcholine (ACh), a major parasympathetic neurotransmitter, binds to Gq-coupled receptors and activates phospholipase C- (PLC-), and the stimulatory effects involve activation of protein kinase C (PKC), which stimulates exocytosis. In addition, ACh mobilizes intracellular Ca2+ by activation of IP3 receptors.
CLASS       Organismal Systems; Endocrine system
PATHWAY_MAP hsa04911  Insulin secretion
DRUG        D00219  Acetohexamide (JP18/USP/INN)
            D00271  Chlorpropamide (JP18/USP/INN)
            D00294  Diazoxide (JAN/USP/INN)
            D00335  Glipizide (USP/INN)
            D00336  Glyburide (USP)
            D00379  Tolazamide (JAN/USP/INN)
            D00380  Tolbutamide (JAN/USP/INN)
            D00593  Glimepiride (JP18/USP/INN)
            D00594  Repaglinide (JAN/USP/INN)
            D01111  Nateglinide (JP18/USP/INN)
            D01356  Glymidine sodium (JAN/USAN/INN)
            D01599  Gliclazide (JP18/INN)
            D01799  Glyclopyramide (JAN/INN)
            D01854  Mitiglinide calcium hydrate (JP18)
            D02425  Carbutamide (INN)
            D02427  Glibornuride (USAN/INN)
            D02430  Gliquidone (INN)
            D02693  Devazepide (USAN/INN)
            D02710  Tarazepide (INN)
            D04121  Exenatide (JAN/USAN/INN)
            D04739  Linogliride (USAN/INN)
            D04740  Linogliride fumarate (USAN)
            D06177  Tolbutamide sodium, sterile
            D06404  Liraglutide (USAN/INN)
            D07117  Metahexamide (INN)
            D07118  Glisoxepide (INN)
            D08843  Albiglutide (USAN)
            D09723  Taspoglutide (USAN/INN)
            D09729  Lixisenatide (JAN/USAN/INN)
            D09889  Dulaglutide (USAN/INN)
            D10025  Semaglutide (USAN/INN)
            D10970  Pegapamodutide (USAN/INN)
            D11034  Insulin glargine and lixisenatide
            D11304  Cotadutide (USAN/INN)
            D11360  Tirzepatide (JAN/USAN)
            D11418  Avexitide (USAN/INN)
            D11419  Avexitide acetate (USAN)
            D11567  Insulin degludec and liraglutide
            D11607  Efinopegdutide (USAN/INN)
            D11910  Danuglipron (USAN)
            D11911  Danuglipron tromethamine (USAN)
            D11924  Beinaglutide (INN)
            D11947  Efpeglenatide (USAN/INN)
            D12225  Mazdutide (USAN/INN)
            D12430  Retatrutide (USAN)
            D12529  Orforglipron calcium (USAN)
            D12536  Orforglipron (USAN)
            D12555  Lotiglipron (USAN)
            D12735  Lotiglipron tromethamine (USAN)
            D12861  Pemvidutide (USAN/INN)
            D12898  Survodutide (USAN/INN)
            D12987  Diazoxide choline (USAN)
DBLINKS     GO: 0030073
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        10242  KCNMB2; potassium calcium-activated channel subfamily M regulatory beta subunit 2 [KO:K04938]
            10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]
            107  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]
            108  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]
            109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]
            11069  RAPGEF4; Rap guanine nucleotide exchange factor 4 [KO:K04351]
            111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]
            112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]
            113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]
            1131  CHRM3; cholinergic receptor muscarinic 3 [KO:K04131]
            114  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]
            115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]
            116  ADCYAP1; adenylate cyclase activating polypeptide 1 [KO:K05262]
            117  ADCYAP1R1; ADCYAP receptor type I [KO:K04587]
            1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]
            1386  ATF2; activating transcription factor 2 [KO:K04450]
            1388  ATF6B; activating transcription factor 6 beta [KO:K09049]
            139760  GPR119; G protein-coupled receptor 119 [KO:K08424]
            148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]
            157855  KCNU1; potassium calcium-activated channel subfamily U member 1 [KO:K05274]
            196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]
            23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]
            23439  ATP1B4; ATPase Na+/K+ transporting family member beta 4 [KO:K01540]
            2641  GCG; glucagon [KO:K05259]
            2645  GCK; glucokinase [KO:K12407] [EC:2.7.1.2]
            2695  GIP; gastric inhibitory polypeptide [KO:K05258]
            27094  KCNMB3; potassium calcium-activated channel subfamily M regulatory beta subunit 3 [KO:K04939]
            27345  KCNMB4; potassium calcium-activated channel subfamily M regulatory beta subunit 4 [KO:K04941]
            2740  GLP1R; glucagon like peptide 1 receptor [KO:K04581]
            27445  PCLO; piccolo presynaptic cytomatrix protein [KO:K16882]
            2767  GNA11; G protein subunit alpha 11 [KO:K04635]
            2776  GNAQ; G protein subunit alpha q [KO:K04634]
            2778  GNAS; GNAS complex locus [KO:K04632]
            2864  FFAR1; free fatty acid receptor 1 [KO:K04325]
            3630  INS; insulin [KO:K04526]
            3651  PDX1; pancreatic and duodenal homeobox 1 [KO:K07594]
            3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
            3767  KCNJ11; potassium inwardly rectifying channel subfamily J member 11 [KO:K05004]
            3778  KCNMA1; potassium calcium-activated channel subfamily M alpha 1 [KO:K04936]
            3779  KCNMB1; potassium calcium-activated channel subfamily M regulatory beta subunit 1 [KO:K04937]
            3780  KCNN1; potassium calcium-activated channel subfamily N member 1 [KO:K04942]
            3781  KCNN2; potassium calcium-activated channel subfamily N member 2 [KO:K04943]
            3782  KCNN3; potassium calcium-activated channel subfamily N member 3 [KO:K04944]
            3783  KCNN4; potassium calcium-activated channel subfamily N member 4 [KO:K04945]
            468  ATF4; activating transcription factor 4 [KO:K04374]
            476  ATP1A1; ATPase Na+/K+ transporting subunit alpha 1 [KO:K01539] [EC:7.2.2.13]
            477  ATP1A2; ATPase Na+/K+ transporting subunit alpha 2 [KO:K01539] [EC:7.2.2.13]
            478  ATP1A3; ATPase Na+/K+ transporting subunit alpha 3 [KO:K01539] [EC:7.2.2.13]
            480  ATP1A4; ATPase Na+/K+ transporting subunit alpha 4 [KO:K01539] [EC:7.2.2.13]
            481  ATP1B1; ATPase Na+/K+ transporting subunit beta 1 [KO:K01540]
            482  ATP1B2; ATPase Na+/K+ transporting subunit beta 2 [KO:K01540]
            483  ATP1B3; ATPase Na+/K+ transporting subunit beta 3 [KO:K01540]
            486  FXYD2; FXYD domain containing ion transport regulator 2 [KO:K01538]
            5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]
            5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]
            5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]
            54795  TRPM4; transient receptor potential cation channel subfamily M member 4 [KO:K04979]
            5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
            5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
            5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]
            5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
            5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
            5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
            5864  RAB3A; RAB3A, member RAS oncogene family [KO:K07882]
            6262  RYR2; ryanodine receptor 2 [KO:K04962]
            64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]
            6513  SLC2A1; solute carrier family 2 member 1 [KO:K07299]
            6514  SLC2A2; solute carrier family 2 member 2 [KO:K07593]
            6616  SNAP25; synaptosome associated protein 25 [KO:K18211]
            6804  STX1A; syntaxin 1A [KO:K04560]
            6833  ABCC8; ATP binding cassette subfamily C member 8 [KO:K05032]
            6844  VAMP2; vesicle associated membrane protein 2 [KO:K13504]
            775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]
            776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]
            778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]
            779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]
            815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]
            816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]
            817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]
            818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]
            84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]
            885  CCK; cholecystokinin [KO:K05226]
            886  CCKAR; cholecystokinin A receptor [KO:K04194]
            90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]
            9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]
            9699  RIMS2; regulating synaptic membrane exocytosis 2 [KO:K15297]
COMPOUND    C00002  ATP
            C00022  Pyruvate
            C00031  D-Glucose
            C00076  Calcium cation
            C00092  D-Glucose 6-phosphate
            C00162  Fatty acid
            C00165  Diacylglycerol
            C00238  Potassium cation
            C00575  3',5'-Cyclic AMP
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C01330  Sodium cation
            C01996  Acetylcholine
REFERENCE   PMID:20551594
  AUTHORS   Seino S, Shibasaki T, Minami K
  TITLE     Pancreatic beta-cell signaling: toward better understanding of diabetes and its treatment.
  JOURNAL   Proc Jpn Acad Ser B Phys Biol Sci 86:563-77 (2010)
            DOI:10.2183/pjab.86.563
REFERENCE   PMID:20225132
  AUTHORS   Jitrapakdee S, Wutthisathapornchai A, Wallace JC, MacDonald MJ
  TITLE     Regulation of insulin secretion: role of mitochondrial signalling.
  JOURNAL   Diabetologia 53:1019-32 (2010)
            DOI:10.1007/s00125-010-1685-0
REFERENCE   PMID:22974438
  AUTHORS   Rorsman P, Braun M
  TITLE     Regulation of insulin secretion in human pancreatic islets.
  JOURNAL   Annu Rev Physiol 75:155-79 (2013)
            DOI:10.1146/annurev-physiol-030212-183754
REFERENCE   PMID:9715374
  AUTHORS   Jones PM, Persaud SJ
  TITLE     Protein kinases, protein phosphorylation, and the regulation of insulin secretion from pancreatic beta-cells.
  JOURNAL   Endocr Rev 19:429-61 (1998)
            DOI:10.1210/edrv.19.4.0339
REFERENCE   PMID:21934040
  AUTHORS   MacDonald PE
  TITLE     Signal integration at the level of ion channel and exocytotic function in pancreatic beta-cells.
  JOURNAL   Am J Physiol Endocrinol Metab 301:E1065-9 (2011)
            DOI:10.1152/ajpendo.00426.2011
REFERENCE   PMID:9914469
  AUTHORS   Lang J
  TITLE     Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion.
  JOURNAL   Eur J Biochem 259:3-17 (1999)
            DOI:10.1046/j.1432-1327.1999.00043.x
REFERENCE   PMID:10605628
  AUTHORS   Kieffer TJ, Habener JF
  TITLE     The glucagon-like peptides.
  JOURNAL   Endocr Rev 20:876-913 (1999)
            DOI:10.1210/edrv.20.6.0385
REFERENCE   PMID:19036624
  AUTHORS   Girard J
  TITLE     The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions.
  JOURNAL   Diabetes Metab 34:550-9 (2008)
            DOI:10.1016/j.diabet.2008.09.001
REFERENCE   PMID:15655710
  AUTHORS   Holz GG
  TITLE     New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.
  JOURNAL   Horm Metab Res 36:787-94 (2004)
            DOI:10.1055/s-2004-826165
REFERENCE   PMID:15271645
  AUTHORS   Holst JJ, Gromada J
  TITLE     Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.
  JOURNAL   Am J Physiol Endocrinol Metab 287:E199-206 (2004)
            DOI:10.1152/ajpendo.00545.2003
REFERENCE   PMID:17306374
  AUTHORS   Doyle ME, Egan JM
  TITLE     Mechanisms of action of glucagon-like peptide 1 in the pancreas.
  JOURNAL   Pharmacol Ther 113:546-93 (2007)
            DOI:10.1016/j.pharmthera.2006.11.007
REFERENCE   PMID:19074620
  AUTHORS   Kim W, Egan JM
  TITLE     The role of incretins in glucose homeostasis and diabetes treatment.
  JOURNAL   Pharmacol Rev 60:470-512 (2008)
            DOI:10.1124/pr.108.000604
REFERENCE   PMID:19817800
  AUTHORS   Seino S, Takahashi H, Fujimoto W, Shibasaki T
  TITLE     Roles of cAMP signalling in insulin granule exocytosis.
  JOURNAL   Diabetes Obes Metab 11 Suppl 4:180-8 (2009)
            DOI:10.1111/j.1463-1326.2009.01108.x
REFERENCE   PMID:22970724
  AUTHORS   Tengholm A
  TITLE     Cyclic AMP dynamics in the pancreatic beta-cell.
  JOURNAL   Ups J Med Sci 117:355-69 (2012)
            DOI:10.3109/03009734.2012.724732
REFERENCE   PMID:14693691
  AUTHORS   Holz GG
  TITLE     Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell.
  JOURNAL   Diabetes 53:5-13 (2004)
            DOI:10.2337/diabetes.53.1.5
REFERENCE   PMID:20055708
  AUTHORS   Gloerich M, Bos JL
  TITLE     Epac: defining a new mechanism for cAMP action.
  JOURNAL   Annu Rev Pharmacol Toxicol 50:355-75 (2010)
            DOI:10.1146/annurev.pharmtox.010909.105714
REFERENCE   PMID:17084085
  AUTHORS   Bos JL
  TITLE     Epac proteins: multi-purpose cAMP targets.
  JOURNAL   Trends Biochem Sci 31:680-6 (2006)
            DOI:10.1016/j.tibs.2006.10.002
REFERENCE   PMID:11522660
  AUTHORS   Filipsson K, Kvist-Reimer M, Ahren B
  TITLE     The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function.
  JOURNAL   Diabetes 50:1959-69 (2001)
            DOI:10.2337/diabetes.50.9.1959
REFERENCE   PMID:19817784
  AUTHORS   Kebede MA, Alquier T, Latour MG, Poitout V
  TITLE     Lipid receptors and islet function: therapeutic implications?
  JOURNAL   Diabetes Obes Metab 11 Suppl 4:10-20 (2009)
            DOI:10.1111/j.1463-1326.2009.01114.x
REFERENCE   PMID:19660440
  AUTHORS   Morgan NG, Dhayal S
  TITLE     G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell.
  JOURNAL   Biochem Pharmacol 78:1419-27 (2009)
            DOI:10.1016/j.bcp.2009.07.020
REL_PATHWAY hsa00020  Citrate cycle (TCA cycle)
            hsa04020  Calcium signaling pathway
KO_PATHWAY  ko04911
///
